The global Cancer Recurrence Monitoring Kit market was valued at US$ 1520 million in 2023 and is anticipated to reach US$ 3355.5 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.

Cancer Recurrence Monitoring Kit Market

The Cancer Recurrence Monitoring Kit is a medical diagnostic tool used to detect whether patients who have been diagnosed with cancer have experienced recurrence or progression of the cancer after treatment. These test kits are typically evaluated by detecting biomarkers or tumor markers in a patient's body fluids, such as blood, urine, or saliva. These markers are proteins, cells or genes associated with cancer, and their presence or changes in levels can indicate the recurrence of cancer.

Cancer recurrence monitoring kit is one of the important products in the field of medical diagnosis and has a wide market demand. This market prospect continues to grow with increasing number of cancer patients and increasing pursuit of early diagnosis and treatment. The size and growth potential of the market may be affected by a variety of factors, including the increase in cancer patients, technological advancements, improvements in the healthcare system, etc.

This report aims to provide a comprehensive presentation of the global market for Cancer Recurrence Monitoring Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Recurrence Monitoring Kit.

Report Scope

The Cancer Recurrence Monitoring Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Recurrence Monitoring Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Recurrence Monitoring Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Recurrence Monitoring Kit Market Report

Report Metric	Details
Report Name	Cancer Recurrence Monitoring Kit Market
Accounted market size in 2023	US$ 1520 million
Forecasted market size in 2030	US$ 3355.5 million
CAGR	12.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Blood Cancer Bone Cancer
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	SeekIn, Guardant Health, Neoimmune, Labcorp Inc, F.Hoffmann-La Roche Ltd., Cergentis B.V., Sysmex Corporation, NeoGenomics Laboratories, Inc., Adaptive, Biotechnologies Corporation, ArcherDX, Inc., Asuragen Inc., Arup Laboratories Inc., Bio-Rad Laboratories, Opko Health, Quest Diagnostics, ICON plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Recurrence Monitoring Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Recurrence Monitoring Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Recurrence Monitoring Kit Market growing?

Ans: The Cancer Recurrence Monitoring Kit Market witnessing a CAGR of 12.0% during the forecast period 2024-2030.

What is the Cancer Recurrence Monitoring Kit Market size in 2030?

Ans: The Cancer Recurrence Monitoring Kit Market size in 2030 will be US$ 3355.5 million.

Who are the main players in the Cancer Recurrence Monitoring Kit Market report?

Ans: The main players in the Cancer Recurrence Monitoring Kit Market are SeekIn, Guardant Health, Neoimmune, Labcorp Inc, F.Hoffmann-La Roche Ltd., Cergentis B.V., Sysmex Corporation, NeoGenomics Laboratories, Inc., Adaptive, Biotechnologies Corporation, ArcherDX, Inc., Asuragen Inc., Arup Laboratories Inc., Bio-Rad Laboratories, Opko Health, Quest Diagnostics, ICON plc

What are the Application segmentation covered in the Cancer Recurrence Monitoring Kit Market report?

Ans: The Applications covered in the Cancer Recurrence Monitoring Kit Market report are Hospital, Clinic

What are the Type segmentation covered in the Cancer Recurrence Monitoring Kit Market report?

Ans: The Types covered in the Cancer Recurrence Monitoring Kit Market report are Blood Cancer, Bone Cancer

1 Cancer Recurrence Monitoring Kit Market Overview

1.1 Product Overview and Scope of Cancer Recurrence Monitoring Kit

1.2 Cancer Recurrence Monitoring Kit Segment by Type

1.2.1 Global Cancer Recurrence Monitoring Kit Market Value Comparison by Type (2024-2030)

1.2.2 Blood Cancer

1.2.3 Bone Cancer

1.3 Cancer Recurrence Monitoring Kit Segment by Application

1.3.1 Global Cancer Recurrence Monitoring Kit Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Cancer Recurrence Monitoring Kit Market Size Estimates and Forecasts

1.4.1 Global Cancer Recurrence Monitoring Kit Revenue 2019-2030

1.4.2 Global Cancer Recurrence Monitoring Kit Sales 2019-2030

1.4.3 Global Cancer Recurrence Monitoring Kit Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Cancer Recurrence Monitoring Kit Market Competition by Manufacturers

2.1 Global Cancer Recurrence Monitoring Kit Sales Market Share by Manufacturers (2019-2024)

2.2 Global Cancer Recurrence Monitoring Kit Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Cancer Recurrence Monitoring Kit Average Price by Manufacturers (2019-2024)

2.4 Global Cancer Recurrence Monitoring Kit Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Cancer Recurrence Monitoring Kit, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Cancer Recurrence Monitoring Kit, Product Type & Application

2.7 Cancer Recurrence Monitoring Kit Market Competitive Situation and Trends

2.7.1 Cancer Recurrence Monitoring Kit Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Cancer Recurrence Monitoring Kit Players Market Share by Revenue

2.7.3 Global Cancer Recurrence Monitoring Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cancer Recurrence Monitoring Kit Retrospective Market Scenario by Region

3.1 Global Cancer Recurrence Monitoring Kit Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Cancer Recurrence Monitoring Kit Global Cancer Recurrence Monitoring Kit Sales by Region: 2019-2030

3.2.1 Global Cancer Recurrence Monitoring Kit Sales by Region: 2019-2024

3.2.2 Global Cancer Recurrence Monitoring Kit Sales by Region: 2025-2030

3.3 Global Cancer Recurrence Monitoring Kit Global Cancer Recurrence Monitoring Kit Revenue by Region: 2019-2030

3.3.1 Global Cancer Recurrence Monitoring Kit Revenue by Region: 2019-2024

3.3.2 Global Cancer Recurrence Monitoring Kit Revenue by Region: 2025-2030

3.4 North America Cancer Recurrence Monitoring Kit Market Facts & Figures by Country

3.4.1 North America Cancer Recurrence Monitoring Kit Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Cancer Recurrence Monitoring Kit Sales by Country (2019-2030)

3.4.3 North America Cancer Recurrence Monitoring Kit Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Cancer Recurrence Monitoring Kit Market Facts & Figures by Country

3.5.1 Europe Cancer Recurrence Monitoring Kit Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Cancer Recurrence Monitoring Kit Sales by Country (2019-2030)

3.5.3 Europe Cancer Recurrence Monitoring Kit Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Cancer Recurrence Monitoring Kit Market Facts & Figures by Country

3.6.1 Asia Pacific Cancer Recurrence Monitoring Kit Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Cancer Recurrence Monitoring Kit Sales by Country (2019-2030)

3.6.3 Asia Pacific Cancer Recurrence Monitoring Kit Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Cancer Recurrence Monitoring Kit Market Facts & Figures by Country

3.7.1 Latin America Cancer Recurrence Monitoring Kit Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Cancer Recurrence Monitoring Kit Sales by Country (2019-2030)

3.7.3 Latin America Cancer Recurrence Monitoring Kit Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Cancer Recurrence Monitoring Kit Market Facts & Figures by Country

3.8.1 Middle East and Africa Cancer Recurrence Monitoring Kit Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Cancer Recurrence Monitoring Kit Sales by Country (2019-2030)

3.8.3 Middle East and Africa Cancer Recurrence Monitoring Kit Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Cancer Recurrence Monitoring Kit Sales by Type (2019-2030)

4.1.1 Global Cancer Recurrence Monitoring Kit Sales by Type (2019-2024)

4.1.2 Global Cancer Recurrence Monitoring Kit Sales by Type (2025-2030)

4.1.3 Global Cancer Recurrence Monitoring Kit Sales Market Share by Type (2019-2030)

4.2 Global Cancer Recurrence Monitoring Kit Revenue by Type (2019-2030)

4.2.1 Global Cancer Recurrence Monitoring Kit Revenue by Type (2019-2024)

4.2.2 Global Cancer Recurrence Monitoring Kit Revenue by Type (2025-2030)

4.2.3 Global Cancer Recurrence Monitoring Kit Revenue Market Share by Type (2019-2030)

4.3 Global Cancer Recurrence Monitoring Kit Price by Type (2019-2030)

5 Segment by Application

5.1 Global Cancer Recurrence Monitoring Kit Sales by Application (2019-2030)

5.1.1 Global Cancer Recurrence Monitoring Kit Sales by Application (2019-2024)

5.1.2 Global Cancer Recurrence Monitoring Kit Sales by Application (2025-2030)

5.1.3 Global Cancer Recurrence Monitoring Kit Sales Market Share by Application (2019-2030)

5.2 Global Cancer Recurrence Monitoring Kit Revenue by Application (2019-2030)

5.2.1 Global Cancer Recurrence Monitoring Kit Revenue by Application (2019-2024)

5.2.2 Global Cancer Recurrence Monitoring Kit Revenue by Application (2025-2030)

5.2.3 Global Cancer Recurrence Monitoring Kit Revenue Market Share by Application (2019-2030)

5.3 Global Cancer Recurrence Monitoring Kit Price by Application (2019-2030)

6 Key Companies Profiled

6.1 SeekIn

6.1.1 SeekIn Corporation Information

6.1.2 SeekIn Description and Business Overview

6.1.3 SeekIn Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.1.4 SeekIn Cancer Recurrence Monitoring Kit Product Portfolio

6.1.5 SeekIn Recent Developments/Updates

6.2 Guardant Health

6.2.1 Guardant Health Corporation Information

6.2.2 Guardant Health Description and Business Overview

6.2.3 Guardant Health Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Guardant Health Cancer Recurrence Monitoring Kit Product Portfolio

6.2.5 Guardant Health Recent Developments/Updates

6.3 Neoimmune

6.3.1 Neoimmune Corporation Information

6.3.2 Neoimmune Description and Business Overview

6.3.3 Neoimmune Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Neoimmune Cancer Recurrence Monitoring Kit Product Portfolio

6.3.5 Neoimmune Recent Developments/Updates

6.4 Labcorp Inc

6.4.1 Labcorp Inc Corporation Information

6.4.2 Labcorp Inc Description and Business Overview

6.4.3 Labcorp Inc Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Labcorp Inc Cancer Recurrence Monitoring Kit Product Portfolio

6.4.5 Labcorp Inc Recent Developments/Updates

6.5 F.Hoffmann-La Roche Ltd.

6.5.1 F.Hoffmann-La Roche Ltd. Corporation Information

6.5.2 F.Hoffmann-La Roche Ltd. Description and Business Overview

6.5.3 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.5.4 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product Portfolio

6.5.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates

6.6 Cergentis B.V.

6.6.1 Cergentis B.V. Corporation Information

6.6.2 Cergentis B.V. Description and Business Overview

6.6.3 Cergentis B.V. Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Cergentis B.V. Cancer Recurrence Monitoring Kit Product Portfolio

6.6.5 Cergentis B.V. Recent Developments/Updates

6.7 Sysmex Corporation

6.6.1 Sysmex Corporation Corporation Information

6.6.2 Sysmex Corporation Description and Business Overview

6.6.3 Sysmex Corporation Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sysmex Corporation Cancer Recurrence Monitoring Kit Product Portfolio

6.7.5 Sysmex Corporation Recent Developments/Updates

6.8 NeoGenomics Laboratories, Inc.

6.8.1 NeoGenomics Laboratories, Inc. Corporation Information

6.8.2 NeoGenomics Laboratories, Inc. Description and Business Overview

6.8.3 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.8.4 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product Portfolio

6.8.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates

6.9 Adaptive

6.9.1 Adaptive Corporation Information

6.9.2 Adaptive Description and Business Overview

6.9.3 Adaptive Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Adaptive Cancer Recurrence Monitoring Kit Product Portfolio

6.9.5 Adaptive Recent Developments/Updates

6.10 Biotechnologies Corporation

6.10.1 Biotechnologies Corporation Corporation Information

6.10.2 Biotechnologies Corporation Description and Business Overview

6.10.3 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product Portfolio

6.10.5 Biotechnologies Corporation Recent Developments/Updates

6.11 ArcherDX, Inc.

6.11.1 ArcherDX, Inc. Corporation Information

6.11.2 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Description and Business Overview

6.11.3 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.11.4 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product Portfolio

6.11.5 ArcherDX, Inc. Recent Developments/Updates

6.12 Asuragen Inc.

6.12.1 Asuragen Inc. Corporation Information

6.12.2 Asuragen Inc. Cancer Recurrence Monitoring Kit Description and Business Overview

6.12.3 Asuragen Inc. Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Asuragen Inc. Cancer Recurrence Monitoring Kit Product Portfolio

6.12.5 Asuragen Inc. Recent Developments/Updates

6.13 Arup Laboratories Inc.

6.13.1 Arup Laboratories Inc. Corporation Information

6.13.2 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Description and Business Overview

6.13.3 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product Portfolio

6.13.5 Arup Laboratories Inc. Recent Developments/Updates

6.14 Bio-Rad Laboratories

6.14.1 Bio-Rad Laboratories Corporation Information

6.14.2 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Description and Business Overview

6.14.3 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product Portfolio

6.14.5 Bio-Rad Laboratories Recent Developments/Updates

6.15 Opko Health

6.15.1 Opko Health Corporation Information

6.15.2 Opko Health Cancer Recurrence Monitoring Kit Description and Business Overview

6.15.3 Opko Health Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Opko Health Cancer Recurrence Monitoring Kit Product Portfolio

6.15.5 Opko Health Recent Developments/Updates

6.16 Quest Diagnostics

6.16.1 Quest Diagnostics Corporation Information

6.16.2 Quest Diagnostics Cancer Recurrence Monitoring Kit Description and Business Overview

6.16.3 Quest Diagnostics Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Quest Diagnostics Cancer Recurrence Monitoring Kit Product Portfolio

6.16.5 Quest Diagnostics Recent Developments/Updates

6.17 ICON plc

6.17.1 ICON plc Corporation Information

6.17.2 ICON plc Cancer Recurrence Monitoring Kit Description and Business Overview

6.17.3 ICON plc Cancer Recurrence Monitoring Kit Sales, Revenue and Gross Margin (2019-2024)

6.17.4 ICON plc Cancer Recurrence Monitoring Kit Product Portfolio

6.17.5 ICON plc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Cancer Recurrence Monitoring Kit Industry Chain Analysis

7.2 Cancer Recurrence Monitoring Kit Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Cancer Recurrence Monitoring Kit Production Mode & Process

7.4 Cancer Recurrence Monitoring Kit Sales and Marketing

7.4.1 Cancer Recurrence Monitoring Kit Sales Channels

7.4.2 Cancer Recurrence Monitoring Kit Distributors

7.5 Cancer Recurrence Monitoring Kit Customers

8 Cancer Recurrence Monitoring Kit Market Dynamics

8.1 Cancer Recurrence Monitoring Kit Industry Trends

8.2 Cancer Recurrence Monitoring Kit Market Drivers

8.3 Cancer Recurrence Monitoring Kit Market Challenges

8.4 Cancer Recurrence Monitoring Kit Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Guardant Health

LabCorp

F Hoffmann La Roche Ltd

Cergentis B.V.

Sysmex Corporation

NeoGenomics Laboratories Inc.

Adaptive

Archerdx

Asuragen

ARUP Laboratories, Inc

Biotechnologies Corporation

List of Tables

Table 1. Global Cancer Recurrence Monitoring Kit Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Cancer Recurrence Monitoring Kit Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Cancer Recurrence Monitoring Kit Market Competitive Situation by Manufacturers in 2023

Table 4. Global Cancer Recurrence Monitoring Kit Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Cancer Recurrence Monitoring Kit Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Cancer Recurrence Monitoring Kit Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Cancer Recurrence Monitoring Kit Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Cancer Recurrence Monitoring Kit Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Cancer Recurrence Monitoring Kit, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Cancer Recurrence Monitoring Kit, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Cancer Recurrence Monitoring Kit, Product Type & Application

Table 12. Global Key Manufacturers of Cancer Recurrence Monitoring Kit, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Cancer Recurrence Monitoring Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Recurrence Monitoring Kit as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Cancer Recurrence Monitoring Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Cancer Recurrence Monitoring Kit Sales by Region (2019-2024) & (K Units)

Table 18. Global Cancer Recurrence Monitoring Kit Sales Market Share by Region (2019-2024)

Table 19. Global Cancer Recurrence Monitoring Kit Sales by Region (2025-2030) & (K Units)

Table 20. Global Cancer Recurrence Monitoring Kit Sales Market Share by Region (2025-2030)

Table 21. Global Cancer Recurrence Monitoring Kit Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Cancer Recurrence Monitoring Kit Revenue Market Share by Region (2019-2024)

Table 23. Global Cancer Recurrence Monitoring Kit Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Cancer Recurrence Monitoring Kit Revenue Market Share by Region (2025-2030)

Table 25. North America Cancer Recurrence Monitoring Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Cancer Recurrence Monitoring Kit Sales by Country (2019-2024) & (K Units)

Table 27. North America Cancer Recurrence Monitoring Kit Sales by Country (2025-2030) & (K Units)

Table 28. North America Cancer Recurrence Monitoring Kit Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Cancer Recurrence Monitoring Kit Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Cancer Recurrence Monitoring Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Cancer Recurrence Monitoring Kit Sales by Country (2019-2024) & (K Units)

Table 32. Europe Cancer Recurrence Monitoring Kit Sales by Country (2025-2030) & (K Units)

Table 33. Europe Cancer Recurrence Monitoring Kit Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Cancer Recurrence Monitoring Kit Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Cancer Recurrence Monitoring Kit Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Cancer Recurrence Monitoring Kit Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Cancer Recurrence Monitoring Kit Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Cancer Recurrence Monitoring Kit Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Cancer Recurrence Monitoring Kit Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Cancer Recurrence Monitoring Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Cancer Recurrence Monitoring Kit Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Cancer Recurrence Monitoring Kit Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Cancer Recurrence Monitoring Kit Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Cancer Recurrence Monitoring Kit Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Cancer Recurrence Monitoring Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Cancer Recurrence Monitoring Kit Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Cancer Recurrence Monitoring Kit Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Cancer Recurrence Monitoring Kit Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Cancer Recurrence Monitoring Kit Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Cancer Recurrence Monitoring Kit Sales (K Units) by Type (2019-2024)

Table 51. Global Cancer Recurrence Monitoring Kit Sales (K Units) by Type (2025-2030)

Table 52. Global Cancer Recurrence Monitoring Kit Sales Market Share by Type (2019-2024)

Table 53. Global Cancer Recurrence Monitoring Kit Sales Market Share by Type (2025-2030)

Table 54. Global Cancer Recurrence Monitoring Kit Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Cancer Recurrence Monitoring Kit Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Cancer Recurrence Monitoring Kit Revenue Market Share by Type (2019-2024)

Table 57. Global Cancer Recurrence Monitoring Kit Revenue Market Share by Type (2025-2030)

Table 58. Global Cancer Recurrence Monitoring Kit Price (US$/Unit) by Type (2019-2024)

Table 59. Global Cancer Recurrence Monitoring Kit Price (US$/Unit) by Type (2025-2030)

Table 60. Global Cancer Recurrence Monitoring Kit Sales (K Units) by Application (2019-2024)

Table 61. Global Cancer Recurrence Monitoring Kit Sales (K Units) by Application (2025-2030)

Table 62. Global Cancer Recurrence Monitoring Kit Sales Market Share by Application (2019-2024)

Table 63. Global Cancer Recurrence Monitoring Kit Sales Market Share by Application (2025-2030)

Table 64. Global Cancer Recurrence Monitoring Kit Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Cancer Recurrence Monitoring Kit Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Cancer Recurrence Monitoring Kit Revenue Market Share by Application (2019-2024)

Table 67. Global Cancer Recurrence Monitoring Kit Revenue Market Share by Application (2025-2030)

Table 68. Global Cancer Recurrence Monitoring Kit Price (US$/Unit) by Application (2019-2024)

Table 69. Global Cancer Recurrence Monitoring Kit Price (US$/Unit) by Application (2025-2030)

Table 70. SeekIn Corporation Information

Table 71. SeekIn Description and Business Overview

Table 72. SeekIn Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. SeekIn Cancer Recurrence Monitoring Kit Product

Table 74. SeekIn Recent Developments/Updates

Table 75. Guardant Health Corporation Information

Table 76. Guardant Health Description and Business Overview

Table 77. Guardant Health Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Guardant Health Cancer Recurrence Monitoring Kit Product

Table 79. Guardant Health Recent Developments/Updates

Table 80. Neoimmune Corporation Information

Table 81. Neoimmune Description and Business Overview

Table 82. Neoimmune Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Neoimmune Cancer Recurrence Monitoring Kit Product

Table 84. Neoimmune Recent Developments/Updates

Table 85. Labcorp Inc Corporation Information

Table 86. Labcorp Inc Description and Business Overview

Table 87. Labcorp Inc Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Labcorp Inc Cancer Recurrence Monitoring Kit Product

Table 89. Labcorp Inc Recent Developments/Updates

Table 90. F.Hoffmann-La Roche Ltd. Corporation Information

Table 91. F.Hoffmann-La Roche Ltd. Description and Business Overview

Table 92. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product

Table 94. F.Hoffmann-La Roche Ltd. Recent Developments/Updates

Table 95. Cergentis B.V. Corporation Information

Table 96. Cergentis B.V. Description and Business Overview

Table 97. Cergentis B.V. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Cergentis B.V. Cancer Recurrence Monitoring Kit Product

Table 99. Cergentis B.V. Recent Developments/Updates

Table 100. Sysmex Corporation Corporation Information

Table 101. Sysmex Corporation Description and Business Overview

Table 102. Sysmex Corporation Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Sysmex Corporation Cancer Recurrence Monitoring Kit Product

Table 104. Sysmex Corporation Recent Developments/Updates

Table 105. NeoGenomics Laboratories, Inc. Corporation Information

Table 106. NeoGenomics Laboratories, Inc. Description and Business Overview

Table 107. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product

Table 109. NeoGenomics Laboratories, Inc. Recent Developments/Updates

Table 110. Adaptive Corporation Information

Table 111. Adaptive Description and Business Overview

Table 112. Adaptive Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Adaptive Cancer Recurrence Monitoring Kit Product

Table 114. Adaptive Recent Developments/Updates

Table 115. Biotechnologies Corporation Corporation Information

Table 116. Biotechnologies Corporation Description and Business Overview

Table 117. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product

Table 119. Biotechnologies Corporation Recent Developments/Updates

Table 120. ArcherDX, Inc. Corporation Information

Table 121. ArcherDX, Inc. Description and Business Overview

Table 122. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product

Table 124. ArcherDX, Inc. Recent Developments/Updates

Table 125. Asuragen Inc. Corporation Information

Table 126. Asuragen Inc. Description and Business Overview

Table 127. Asuragen Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Asuragen Inc. Cancer Recurrence Monitoring Kit Product

Table 129. Asuragen Inc. Recent Developments/Updates

Table 130. Arup Laboratories Inc. Corporation Information

Table 131. Arup Laboratories Inc. Description and Business Overview

Table 132. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product

Table 134. Arup Laboratories Inc. Recent Developments/Updates

Table 135. Bio-Rad Laboratories Corporation Information

Table 136. Bio-Rad Laboratories Description and Business Overview

Table 137. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product

Table 139. Bio-Rad Laboratories Recent Developments/Updates

Table 140. Opko Health Corporation Information

Table 141. Opko Health Description and Business Overview

Table 142. Opko Health Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Opko Health Cancer Recurrence Monitoring Kit Product

Table 144. Opko Health Recent Developments/Updates

Table 145. Quest Diagnostics Corporation Information

Table 146. Quest Diagnostics Description and Business Overview

Table 147. Quest Diagnostics Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Quest Diagnostics Cancer Recurrence Monitoring Kit Product

Table 149. Quest Diagnostics Recent Developments/Updates

Table 150. ICON plc Corporation Information

Table 151. ICON plc Description and Business Overview

Table 152. ICON plc Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. ICON plc Cancer Recurrence Monitoring Kit Product

Table 154. ICON plc Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Cancer Recurrence Monitoring Kit Distributors List

Table 158. Cancer Recurrence Monitoring Kit Customers List

Table 159. Cancer Recurrence Monitoring Kit Market Trends

Table 160. Cancer Recurrence Monitoring Kit Market Drivers

Table 161. Cancer Recurrence Monitoring Kit Market Challenges

Table 162. Cancer Recurrence Monitoring Kit Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Cancer Recurrence Monitoring Kit

Figure 2. Global Cancer Recurrence Monitoring Kit Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Cancer Recurrence Monitoring Kit Market Share by Type in 2023 & 2030

Figure 4. Blood Cancer Product Picture

Figure 5. Bone Cancer Product Picture

Figure 6. Global Cancer Recurrence Monitoring Kit Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cancer Recurrence Monitoring Kit Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global Cancer Recurrence Monitoring Kit Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Cancer Recurrence Monitoring Kit Market Size (2019-2030) & (US$ Million)

Figure 12. Global Cancer Recurrence Monitoring Kit Sales (2019-2030) & (K Units)

Figure 13. Global Cancer Recurrence Monitoring Kit Average Price (US$/Unit) & (2019-2030)

Figure 14. Cancer Recurrence Monitoring Kit Report Years Considered

Figure 15. Cancer Recurrence Monitoring Kit Sales Share by Manufacturers in 2023

Figure 16. Global Cancer Recurrence Monitoring Kit Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Cancer Recurrence Monitoring Kit Players: Market Share by Revenue in 2023

Figure 18. Cancer Recurrence Monitoring Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Cancer Recurrence Monitoring Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Cancer Recurrence Monitoring Kit Sales Market Share by Country (2019-2030)

Figure 21. North America Cancer Recurrence Monitoring Kit Revenue Market Share by Country (2019-2030)

Figure 22. United States Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Cancer Recurrence Monitoring Kit Sales Market Share by Country (2019-2030)

Figure 25. Europe Cancer Recurrence Monitoring Kit Revenue Market Share by Country (2019-2030)

Figure 26. Germany Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Cancer Recurrence Monitoring Kit Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Cancer Recurrence Monitoring Kit Revenue Market Share by Region (2019-2030)

Figure 33. China Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Cancer Recurrence Monitoring Kit Sales Market Share by Country (2019-2030)

Figure 41. Latin America Cancer Recurrence Monitoring Kit Revenue Market Share by Country (2019-2030)

Figure 42. Mexico Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Cancer Recurrence Monitoring Kit Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Cancer Recurrence Monitoring Kit Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Cancer Recurrence Monitoring Kit Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Cancer Recurrence Monitoring Kit by Type (2019-2030)

Figure 52. Global Revenue Market Share of Cancer Recurrence Monitoring Kit by Type (2019-2030)

Figure 53. Global Cancer Recurrence Monitoring Kit Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Cancer Recurrence Monitoring Kit by Application (2019-2030)

Figure 55. Global Revenue Market Share of Cancer Recurrence Monitoring Kit by Application (2019-2030)

Figure 56. Global Cancer Recurrence Monitoring Kit Price (US$/Unit) by Application (2019-2030)

Figure 57. Cancer Recurrence Monitoring Kit Value Chain

Figure 58. Cancer Recurrence Monitoring Kit Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Oncology Imaging Equipment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1U15802

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global HER2 Tumor Marker Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27D15553

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Targeted Radiotherapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2U15903

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2W15676

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions